Transaction in Own Shares • Apr 29, 2011
Transaction in Own Shares
Open in ViewerOpens in native device viewer
April 29, 2011
On February 11, 2011, Novozymes initiated a share buyback program in accordance with the provisions of European Commission Regulation no. 2273/2003 of December 22, 2003, also referred to as the Safe Harbour Regulation.
Under the program Novozymes will buy back B shares for an amount of up to DKK 400 million in the period from February 11, 2011, to December 31, 2011.
The following transactions have been made under the program:
| Number of shares |
Average purchase price |
Transaction value, DKK |
|
|---|---|---|---|
| Accumulated, last announcement |
126,917 | 99,386,968 | |
| April 15, 2011 | 2,500 | 819.85 | 2,049,625 |
| April 18, 2011 | 7,500 | 822.35 | 6,167,625 |
| April 19, 2011 | 0 | 0 | |
| April 20, 2011 | 0 | 0 | |
| April 26, 2011 | 3,802 | 827.45 | 3,145,965 |
| April 27, 2011 | 3,195 | 826.23 | 2,639,805 |
| April 28, 2011 | 0 | ||
| Accumulated under the program |
143,914 | 113,389,988 |
Transactions related to Novozymes' incentive programs have resulted in a net sale by Novozymes of 4,766 B shares in the period from April 15 to April 28. The shares related to these transactions were not part of the Safe Harbour share buyback program.
With the transactions stated above, Novozymes owns a total of 1,991,555 treasury shares, corresponding to 3.1% of the share capital. The total amount of shares in the company is 65,000,000, including treasury shares.
| Contact persons: | ||
|---|---|---|
| Press and media: | Investor Relations: | |
| René Tronborg (Europe) | Tobias Bjorklund | |
| Tel. (direct): +45 4446 2274 Tel. (mobile): +45 3077 2274 |
Tel. (direct): +45 4446 8682 Tel. (mobile): +45 3077 8682 |
|
| Paige Donnelly (USA) | Martin Riise Nielsen | |
| Tel. (direct): +1 919 494 3209 Tel. (mobile): +1 919 218 4501 |
Tel. (direct): +45 4446 0738 Tel. (mobile): +45 3077 0738 |
|
| Thomas Bomhoff (USA) | ||
| Tel. (direct): +1 919 494 3483 Tel. (mobile): +1 919 649 2565 |
Novozymes is the world leader in bioinnovation. Together with customers across a broad array of industries we create tomorrow's industrial biosolutions, improving our customers' business and the use of our planet's resources. Read more at www.novozymes.com.
Company announcement no. 22, 2011 Page 1 of 1 Novozymes A/S Investor Relations
Krogshoejvej 36 2880 Bagsvaerd Denmark
Telephone: +45 4446 0000 Fax: +45 4446 9999 Internet: www.novozymes.com CVR number: 10 00 71 27
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.